| abstract |
Disclosed herein are 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones of general formula (I), wherein the substituents are as defined in the specification. Said compounds have gestagenic and antimineralocorticoid activity and are suitable for the production of pharmaceutical preparations, for example, for oral contraception and the treatment of pre-, peri- and post-menopausal pain. |